People who received the H1N1 influenza vaccine in 2009 are at a slightly higher risk than the general population for developing Guillain-Barre syndrome, according to a study published in The Lancet. Researchers looked at data from 23 million Americans who got the H1N1 flu shot during the 2009 outbreak and found that 77 developed Guillain-Barre syndrome within 91 days of receiving the vaccine. The vaccine prevented up to 1.5 million cases of flu and as many as 500 deaths, lead researcher Dr. Daniel Salmon said.
H1N1 flu shot may slightly raise risk of Guillain-Barre syndrome
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan